A20 and Tumor Immune Responses
- Institution
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA
- Principal investigator
- Averil I Ma
- Funding
- $553K
- Duration
- 2024–2029
Moonbase score
Still being scored
Abstract
Abstract Immunosuppressive and homeostatic mechanisms prevent immune cells and tissues from eliminating solid tumors, limiting the efficacy of anti-tumor immunity. Precise dissection of these homeostatic mechanisms can lead to better understanding of how tumors persist and grow within tissues. Our prior studies demonstrate that the A20 protein is a potent regulator of immune homeostasis, regulating both pro-inflammatory and cell death signals. Our recent preliminary data reveal that A20 is highly expressed in tumor microenvironments and that one specific biochemical motif of this protein restrains both acute and anamnestic antitumor immunity. This proposal will dissect the cellular and molecular pathways by which A20 regulates anti-tumor immunity.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of California, San FranciscoNot yet scored
Ubiquitination, Intestinal Homeostasis and Cancer
Averil I Ma · $897K · 2022–2027
- NIH · University of California, San FranciscoNot yet scored
INRSA Training Grant in Gastroenterology
Averil I Ma · $274K · 1975–2026
- NIH · University of California, San Francisco66
Dendrite development, function, degeneration and regeneration
Yuh Nung Jan · $676K · 2024–2032